None listed
Conditions
Brief summary
Current research provides strong support that there is a relationship between sleep disturbances and developing many diseases, such as cardiovascular diseases and dementia. This highlights the key role of sleep monitoring in identifying important changes in individual’s sleep at a very early stage. The EMFIT QS (Quantified Sleep), an unobtrusive, contact-free sleep monitoring device, is used for tracking the changes in individual’s sleep. This device provides heart and respiration rate measurements, a sleep stage estimation, sleep quality analysis, and heart rate variability. This study is an open label pilot trial to determine sensor validation.
Interventions
The EMFIT QS (Quantified Sleep), an unobtrusive, contact-free sleep monitoring device, that can be places under a bed mattress and is used for tracking the changes in individual’s sleep. This device provides heart and respiration rate measurements, a sleep stage estimation, sleep quality analysis, and heart rate variability.
Participants underwent a single-night clinical PSG study, and the same sleep measurements from PSG and EMFIT were simultaneously collected. Since EMFIT has been set up unde
The EMFIT QS (Quantified Sleep), an unobtrusive, contact-free sleep monitoring device, that can be places under a bed mattress and is used for tracking the changes in individual’s sleep. This device provides heart and respiration rate measurements, a sleep stage estimation, sleep quality analysis, and heart rate variability. Participants underwent a single-night clinical PSG study, and the same sleep measurements from PSG and EMFIT were simultaneously collected. Since EMFIT has been set up under the mattress, their usual sleep study by PSG has not been disrupted by EMFIT and they didn't notice the existence of the devices under the mattress.
Sponsors
Commonwealth Scientific and Industrial Research Organisation
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
i. Enrolled in the Prince Charles Hospital Sleep Disorders Centre and undergoing some form of sleep study. ii. At least 18 years of age iii. Ability to read and converse in English.
Exclusion criteria
Other illnesses that will limit participation, including cognitive disorders preventing provision of informed consent, insomnia preventing sleep, and medication use that interferes with sleep
Outcome results
None listed